Kindred Biosciences Inc

NASDAQ:KIN   3:59:40 PM EDT
4.43
-0.02 (-0.56%)
Earnings Announcements

Kindred Biosciences Posts Q4 Loss Per Share Of $0.28

Published: 03/16/2021 20:12 GMT
Kindred Biosciences Inc (KIN) - Kindred Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results.
Q4 Loss per Share $0.28.
Q4 Earnings per Share Estimate $-0.29 -- Refinitiv Ibes Data (analyst estimates).
Q4 Revenue $1.0 Million Versus Refinitiv Ibes Estimate of $1 Million.
Revenue is expected to be $2.81 Million
Adjusted EPS is expected to be -$0.24

Next Quarter Revenue Guidance is expected to be $6.53 Million
Next Quarter EPS Guidance is expected to be -$0.16

More details on our Analysts Page.